Inventor
BREITBART EYAL
IL29 patents
⚠️ This page may combine multiple inventors who share the name “BREITBART EYAL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VASCULAR BIOGENICS LTD
18 patentsUS8039261B2Oct 18, 2011
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
VASCULAR BIOGENICS LTD27 citations92
US7989427B2Aug 2, 2011
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
VASCULAR BIOGENICS LTD21 citations92
US7585666B2Sep 8, 2009
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
VASCULAR BIOGENICS LTD29 citations92
US7579327B2Aug 25, 2009
Promoters exhibiting endothelial cell specificity and methods of using same
VASCULAR BIOGENICS LTD23 citations91
US8916378B2Dec 23, 2014
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy
VASCULAR BIOGENICS LTD4 citations83
US8859747B2Oct 14, 2014
Promoters exhibiting endothelial cell specificity and methods of using same
VASCULAR BIOGENICS LTD5 citations82
US9682154B2Jun 20, 2017
Methods of inducing responsiveness to anti-angiogenic agent
VASCULAR BIOGENICS LTD6 citations80
US11697682B2Jul 11, 2023
Motile sperm domain containing protein 2 antibodies and methods of use thereof
VASCULAR BIOGENICS LTD2 citations72
US10022388B2Jul 17, 2018
Oxidized lipids and treatment or prevention of fibrosis
VASCULAR BIOGENICS LTD2 citations71
US11191848B2Dec 7, 2021
Methods of inducing responsiveness to anti-angiogenic agent
VASCULAR BIOGENICS LTD1 citations69
US10383954B2Aug 20, 2019
Methods of inducing responsiveness to anti-angiogenic agent
VASCULAR BIOGENICS LTD4 citations69
US9771385B2Sep 26, 2017
Oxidized lipids
VASCULAR BIOGENICS LTD2 citations69
US9200056B2Dec 1, 2015
FAS-chimera adenovirus vector
VASCULAR BIOGENICS LTD3 citations57
US11311583B2Apr 26, 2022
Treatment methods using adenovirus
VASCULAR BIOGENICS LTD1 citations56
US10206936B2Feb 19, 2019
Oxidized lipids and treatment or prevention of fibrosis
VASCULAR BIOGENICS LTD0 citations50
US10464957B2Nov 5, 2019
Oxidized lipids and methods of use thereof
VASCULAR BIOGENICS LTD0 citations48
US9403887B2Aug 2, 2016
Endothelial cell-specific polynucleotides and use thereof
VASCULAR BIOGENICS LTD0 citations45
US10369196B2Aug 6, 2019
Compositions and methods for treating glioblastoma GBM
VASCULAR BIOGENICS LTD0 citations35
HARATS DROR
6 patentsUS8415318B2Apr 9, 2013
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
HARATS DROR14 citations92
US8206743B2Jun 26, 2012
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
HARATS DROR14 citations91
US8071740B2Dec 6, 2011
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
HARATS DROR19 citations91
US8835398B2Sep 16, 2014
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
HARATS DROR6 citations83
US8859745B2Oct 14, 2014
Promoters exhibiting endothelial cell specificity and methods of using same
HARATS DROR5 citations82
US8846401B2Sep 30, 2014
Promoters exhibiting endothelial cell specificity and methods of using same
HARATS DROR5 citations82